NFKB1 and glioblastoma: Additionally, GBM cells often exhibit aberrant and persistent activation of inflammatory and remodeling pathways, like the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) [11] and altered extracellular matrix (ECM) interactions, contributing to tumor growth, invasion, and resistance to therapies.